Vaccine trial protocols generally do not monitor beyond seven days post-inoculation, and follow-up efforts do not typically ask about menstruation. For this reason, the SARS-CoV-2 vaccine manufacturers have not addressed the phenomenon of unexpected menstrual bleeding, which shows a preponderance of medical misogyny.
“In general, changes in menstrual bleeding are not uncommon or dangerous, but paying attention to these experiences is necessary to build confidence in medicine.”
“Many of our participants say that they would have preferred to be informed of changes in menstrual bleeding before getting vaccinated, because that way they would not have been scared,” said Sinc Kathryn Clancy, author of the University of Illinois.